<ul><li>Canid, a NYC-based developer, raised $10 million to transform pediatric vaccine management with its healthcare dashboard and process tool.</li><li>The funding was led by Telescope Partners and other investors to expand Canid's platform across additional U.S. states and enhance tools for managing pediatric vaccine patient populations.</li><li>Canid, founded in 2020 by CEO Pedro Sanchez de Lozada, aims to simplify vaccine operations for pediatric practices, focusing on purchasing, billing, inventory tracking, and patient outreach.</li><li>The company's platform addresses challenges like vaccine procurement and insurance reimbursements, aiming to improve vaccination rates and public health outcomes especially in under-vaccinated populations.</li></ul>

Canid Funded $10M to Transform Pediatric Vaccine Management

Discover more